Navigation Links
Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/18/2011

ens identifies genes associated with clinical recurrence and prostate cancer–specific survival after radical prostatectomy" (Abstract #4663)

  • Lead Author: Eric A. Klein, Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, Ohio
  • Session Time: 8:00 AM – 12:00 PM
  • Location: Hall A
  • Poster Board: #12G

About the Oncotype DX® Breast Cancer Test*

The Oncotype DX breast cancer test is a multigene expression test that examines a breast cancer patient's tumor tissue at a molecular level, and gives information about their individual disease to help optimize treatment options.  Oncotype DX is the only test incorporated in published ASCO® and NCCN® breast cancer treatment guidelines to predict the likelihood of chemotherapy benefit as well as recurrence for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive.

Additionally, physicians use Oncotype DX to make treatment recommendations for certain node-positive breast cancer patients, and the test report also provides quantitative scores for select individual genes.  Oncotype DX has been extensively evaluated in thirteen clinical studies involving more than 4,000 breast cancer patients worldwide, including a large validation study published in The New England Journal of Medicine and a chemotherapy benefit study published in the Journal of Clinical Oncology.  Both Medicare and private health plans covering over 95 percent of U.S. insured lives provide reimbursement for Oncotype DX for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive through contracts, agreements or policy decisions.  For more information about Oncotype DX for breast cancer
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Personalized Medicine - The Genomic Revolution in Cardiac Care
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... data demonstrates that flibanserin, a novel, non-hormonal medicine being ... dysfunction, Hypoactive Sexual Desire Disorder (HSDD), does not impair ... when taken at bedtime. The data was presented at ... (SMSNA) 20th Annual Fall Scientific Meeting in ... accepted this study as a late breaking abstract for ...
(Date:11/22/2014)... Nov. 21, 2014 Statistics released from a ... driving increase astronomically during the holidays, beginning with Thanksgiving ... cities. The data, highlighted in ... as part of their annual Sober Days ... picture of high-risk drinking and increased rates of DUI ...
(Date:11/22/2014)... HILL, N.C. , Nov. 21, 2014 /PRNewswire/ ... healthcare system. Undoubtedly, the growing influence of patients ... spend for marketing interactions. Now, more than ever, ... retain patients for medical products is essential. ... firm, Best Practices, LLC, benchmarked companies spent about ...
Breaking Medicine Technology:Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3Alarming Stats Show Holiday Drinking an Issue for Many 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2
... Sept. 8 Silence Therapeutics plc (AIM: SLN) ("Silence" ... patents by the United States Patent and Trademark Office ... RNA (siRNA) sequences against the validated cancer targets epidermal ... growth factor receptor 1 (VEGFR1).  EGFR-RP and VEGFR1 have ...
... -- POINT RICHMOND, Calif., Sept. 7 ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
Cached Medicine Technology:Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics 2Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics 3Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics 4Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010 2Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010 3Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010 4Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010 5Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010 6Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010 7
(Date:11/24/2014)... November 24, 2014 Dr. Michael Kettel ... Center, recently appeared on NBC to discuss egg freezing as ... has been trending in the news recently, with new company ... for women. , “[The companies] see it as ... on a career hot path.” Says Dr. Kettel. , Up ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Nearly ... heart attacks, strokes, deep vein thrombosis and other ... a federal multidistrict litigation (MDL) underway in the ... , Court documents updated on November 17th ... (JPML) show the filing of 259 lawsuits against ...
(Date:11/23/2014)... November 23, 2014 This evaluation ... as its significance, programs and manufacturing technological innovation. ... suppliers major market gamers in information. In this ... specifications, prospective, manufacturing value, and 2009-2014 market shares ... evaluation symbolizes the globally and Chinese suppliers finish ...
(Date:11/23/2014)... AngelWeddingDress.com has recently updated its online store, ... dresses. “If you are looking for gorgeous beach wedding ... possible. Here you can enjoy 70% off discounts and ... a big marriage ceremony is the most important dream ... dress is uppermost priority. Ophelia, one of customers, said, ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2
... Texas, Nov. 12 A Fort Worth family has been ... negligence case resulting from improper treatment to a newborn child ... Dallas County by the child,s mother, Tiffany Martinez, and alleged ... to diagnose the hip dysplasia [dislocation] and failed to provide ...
... Mesa Laboratories, Inc. (Nasdaq: MLAB ) today announced ... dividend of $.11 per share of common stock, up from ... payable December 15, 2009, to shareholders of record on November ... has maintained strong cash positions and has continued to build ...
... in day-to-day actions , THURSDAY, Nov. 12 (HealthDay News) -- ... complex decisions, from what to make for dinner to whether ... "Humans make much more complex decisions than other animals -- ... to start a family -- and we wanted to understand ...
... research published in the November issue of the ... that African-American patients with colorectal cancer are more likely ... likely to undergo surgical procedures compared with Caucasians, suggesting ... reduce differences in colorectal cancer outcomes for African-Americans. ...
... ... be crumbling, thanks to a promising new gene therapy that eliminates the ability of certain ... that inactivation of a DNA repair gene called Hus1 efficiently kills cells lacking p53 -- ... ...
... ... lecture at global Alzheimer,s conference on the groundbreaking topic of Alzheimer,s prevention. ... Naples, FL (PRWEB) ... First International Conference on Alzheimer’s Disease and Advanced Neurotechnologies on the topic of Alzheimer,s ...
Cached Medicine News:Health News:Dallas County Jury Finds in Favor of Family in Medical Malpractice Suit 2Health News:What's for Dinner? Brain Chemical Helps People Decide 2Health News:African-Americans with colorectal cancer have poorer outcomes, lower survival rates 2Health News:Cornell Researchers Identify a Weak Link in Cancer Cell Armor 2Health News: Integrative Neurologist Breaks Ground in Alzheimer's Prevention 2
... 1/3 hp. 0-8 scfm/0-29.8 in.hg.@sea level. Incredibly ... to 4 collection canister systems at one ... changes during the procedure. Standard canister set-up ... filters not included). UL, c-UL and CE ...
... is a new term being used today to describe ... liquid fill that may have been used in silicone ... science, this is not new technology cohesive is ... the sticking together nature of the gel. All of ...
This Implant enhances and restores the nasal contour, The large selection of sizes with a variety of flares and lengths allows for more individualized results...
... designed to enhance the chin contour, this chin ... a high-profile central chin projection. Symmetrical Chin ... this implant provides a high central projection, as ... Cleft Chin Implants - Designed with a unique ...
Medicine Products: